Model: fti-sc/pra-sentiment-classifier
Author: fti-sc
Pipeline: text-classification
Library: setfit
Tags: setfit, safetensors, mpnet, sentence-transformers, text-classification, generated_from_setfit_trainer, arxiv:2209.11055, base_model:sentence-transformers/all-mpnet-base-v2, base_model:finetune:sentence-transformers/all-mpnet-base-v2, region:us
Base models (finetune): id: sentence-transformers/all-mpnet-base-v2
Card metadata: tags: setfit, sentence-transformers, text-classification, generated_from_setfit_trainer
widget: "But PBMs operate with little to no transparency within the drug pricing system, and they often take advantage of their opaque position at the expense of patients. Their work includes establishing formularies, contracting with pharmacies, and negotiating rebates and discounts with drug manufacturers. But instead of passing these savings on to consumers, PBMs retain these costs, and the patients do not benefit at the pharmacy counter. But it's actually worse than that. Just as a rising tide lifts all boats, PBMs' rebate manipulation inflates health care prices generally and that ultimately increases the cost of patients' medications.", "That's why our state's local pharmacies are so essential. They provide people access to the care they need when they need it. But now, many pharmacies are under serious threatand our most vulnerable patients along with them. Over the past 14 years, the number of Oregon pharmacies has decreased more than 26%. Accessing medications or treatments should be simple, but unfortunately it's only becoming more difficult. Why is this happening? One reason involves middlemen insurers called pharmacy benefit managers (PBMs).", "But more often, insurers and PBMs have implemented schemes called \"copay accumulator adjustment programs\" that prevent the value of the copay assistance from counting toward a patient's deductible. Faced with unexpectedly high costs at the pharmacy counter, patients impacted by these policies are less likely to adhere to treatment which can lead to worsened health outcomes, increased hospitalizations, and greater costs to the health care system. Copay accumulator policies disproportionately impact communities of color.", "PBMs also compile lists of drugs, called formularies, that providers of health benefits agree to cover; establish pharmacy networks that patients can access; and run their own mail-order pharmacies. Although PBMs are supposed to help lower costs, some of their practices may well do the opposite. PBMs often keep a portion of the rebates they negotiate, which can incentivize them to favor more expensive drugs on their formularies. (A $1 million drug, for example, would fetch a bigger fee than a $100 one.", "This secrecy raises challenging questions. Do PBMs use their size and negotiating power to win lower net prices from drugmakers? Or do PBMs use their dominant market position and opaque business practices to enrich themselves at the expense of their customers and the rest of society? The answer to both these questions is, surprisingly, yes. If the contest for formulary placement works as it should, competition compels drugmakers to offer substantial discounts off the published list price. As a result, insurers and consumers benefit from a reduced net price for drugs. However, formulary competition can be undermined in various ways."
metrics: accuracy
pipeline_tag: text-classification
library_name: setfit
inference: yes
base_model: sentence-transformers/all-mpnet-base-v2
Likes: 0 | All-time downloads: 10
Created: 2025-03-25 19:14:32